Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Commentary/Editorials
Commentary/Editorials
Resistance to systemic immune checkpoint inhibition in the peritoneal niche
Daryl Kai Ann
Chia
,
Yong Xiang
Gwee
,
Raghav
Sundar
Journal for ImmunoTherapy of Cancer
Jun 2022,
10
(6)
e004749;
DOI:
10.1136/jitc-2022-004749
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
Hussein A
Tawbi
,
Ryan J
Sullivan
,
David
Feltquate
,
Theresa
LaVallee
,
Naiyer A
Rizvi
,
Elad
Sharon
,
Jeffrey
Sosman
,
Harriet M
Kluger
Journal for ImmunoTherapy of Cancer
Jul 2023,
11
(7)
e007309;
DOI:
10.1136/jitc-2023-007309
Gasdermin-mediated pyroptosis confers anticancer immunity
Wu
Lin
,
Ben
Lin
,
Quan
Zhou
,
Lisong
Teng
Journal for ImmunoTherapy of Cancer
Jan 2024,
12
(1)
e008162;
DOI:
10.1136/jitc-2023-008162
Commentary on oncolytic viruses: past, present, and future
Christopher
Larson
,
Bryan
Oronsky
,
Tony R
Reid
Journal for ImmunoTherapy of Cancer
Dec 2023,
11
(12)
e007905;
DOI:
10.1136/jitc-2023-007905
Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications
Mario
Sznol
,
Naiyer
Rizvi
Journal for ImmunoTherapy of Cancer
Jan 2023,
11
(1)
e006346;
DOI:
10.1136/jitc-2022-006346
Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies
Mark D.
Stewart
,
Valsamo
Anagnostou
Journal for ImmunoTherapy of Cancer
Jan 2023,
11
(1)
e006367;
DOI:
10.1136/jitc-2022-006367
In memoriam: Soldano Ferrone, MD, PhD (1940–2023)
Theresa
Whiteside
,
Hassane M
Zarour
Journal for ImmunoTherapy of Cancer
Jan 2023,
11
(1)
e006761;
DOI:
10.1136/jitc-2023-006761
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
Margaret
Gatti-Mays
,
James L
Gulley
Journal for ImmunoTherapy of Cancer
Feb 2021,
9
(2)
e002252;
DOI:
10.1136/jitc-2020-002252
Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020)
Martina
Markovska
,
Francesco
Marincola
Journal for ImmunoTherapy of Cancer
Jan 2021,
9
(1)
e002216;
DOI:
10.1136/jitc-2020-002216
Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov
Yi
Que
,
Yang
Hu
,
Dongchun
Hong
,
Yizhuo
Zhang
Journal for ImmunoTherapy of Cancer
Sep 2021,
9
(9)
e002920;
DOI:
10.1136/jitc-2021-002920
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
Special collections
COVID-19
(45)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(560)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(983)
Commentary/Editorials
(153)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(56)
Guidelines and Consensus Statements
(53)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(242)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(437)
Liquid Biopsies
(10)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(151)
Reviews
(245)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(5026)
Press releases
(2)
